Zentalis Pharmaceuticals Inc. (ZNTL): Price and Financial Metrics

Zentalis Pharmaceuticals Inc. (ZNTL): $1.41

0.03 (-2.08%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add ZNTL to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#93 of 307

in industry

ZNTL Price/Volume Stats

Current price $1.41 52-week high $5.44
Prev. close $1.44 52-week low $1.01
Day low $1.41 Volume 412,800
Day high $1.49 Avg. volume 1,330,942
50-day MA $1.32 Dividend yield N/A
200-day MA $0.00 Market Cap 101.45M

ZNTL Stock Price Chart Interactive Chart >


Zentalis Pharmaceuticals Inc. (ZNTL) Company Bio


Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. Its lead product candidate, ZN-c5, is an oral selective estrogen receptor degrader (SERD) for the treatment of estrogen receptor positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) advanced or metastatic breast cancer. The company was founded by Kevin D. Bunker on December 23, 2014 and is headquartered in New York, NY.


ZNTL Latest News Stream


Event/Time News Detail
Loading, please wait...

ZNTL Latest Social Stream


Loading social stream, please wait...

View Full ZNTL Social Stream

ZNTL Price Returns

1-mo 8.46%
3-mo -4.08%
6-mo -37.61%
1-year -61.89%
3-year -94.83%
5-year -96.66%
YTD -53.47%
2024 -80.00%
2023 -24.78%
2022 -76.04%
2021 61.84%
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!